BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Sheng-Han Wang, Shiou-Hwei Yeh, Pei-Jer Chen. Hepatitis C Virus II2016; : 109 doi: 10.1007/978-4-431-56101-9_4
2
Yuan-Yuei Chen, Wen-Hui Fang, Chung-Ching Wang, Tung-Wei Kao, Yaw-Wen Chang, Hui-Fang Yang, Chen-Jung Wu, Yu-Shan Sun, Wei-Liang Chen, Umberto Vespasiani-Gentilucci. Increased body fat percentage in patients with hepatitis B and C virus infectionPLOS ONE 2018; 13(7): e0200164 doi: 10.1371/journal.pone.0200164
3
Che C. Colpitts, Hussein El-Saghire, Nathalie Pochet, Catherine Schuster, Thomas F. Baumert. High-throughput approaches to unravel hepatitis C virus-host interactionsVirus Research 2016; 218: 18 doi: 10.1016/j.virusres.2015.09.013
4
Yasuhiro Matsue, Mikihiro Tsutsumi, Nobuhiko Hayashi, Takashi Saito, Mutsumi Tsuchishima, Nobuyuki Toshikuni, Tomiyasu Arisawa, Joseph George, Ratna B. Ray. Serum Osteopontin Predicts Degree of Hepatic Fibrosis and Serves as a Biomarker in Patients with Hepatitis C Virus InfectionPLOS ONE 2015; 10(3): e0118744 doi: 10.1371/journal.pone.0118744
5
Sara Salehi Hammerstad, Shira Frankel Grock, Hanna J. Lee, Alia Hasham, Nina Sundaram, Yaron Tomer. Diabetes and Hepatitis C: A Two-Way AssociationFrontiers in Endocrinology 2015; 6 doi: 10.3389/fendo.2015.00134
6
Anna Linda Zignego, Manuel Ramos-Casals, Clodoveo Ferri, David Saadoun, Luca Arcaini, Dario Roccatello, Alessandro Antonelli, Anne Claire Desbois, Cloe Comarmond, Laura Gragnani, Milvia Casato, Peter Lamprecht, Alessandra Mangia, Athanasios G Tzioufas, Zobair M Younossi, Patrice Cacoub. International therapeutic guidelines for patients with HCV-related extrahepatic disorders. A multidisciplinary expert statementAutoimmunity Reviews 2017; 16(5): 523 doi: 10.1016/j.autrev.2017.03.004
7
So Mi Kim, Il Han Song. Hepatitis C virus infection in chronic kidney disease: paradigm shift in managementThe Korean Journal of Internal Medicine 2018; 33(4): 670 doi: 10.3904/kjim.2018.202
8
Juli Bai, Feng Liu. The cGAS-cGAMP-STING Pathway: A Molecular Link Between Immunity and MetabolismDiabetes 2019; 68(6): 1099 doi: 10.2337/dbi18-0052
9
Ayman Alsebaey, Mostafa Elhelbawy, Wael Abdel-Razek, Mohammed Hashim, Hassan Elshenawy, Imam Waked. HCV treatment with direct acting antivirals improves the insulin sensitivityExpert Review of Anti-infective Therapy 2019; 17(9): 749 doi: 10.1080/14787210.2019.1653184
10
Ting-ting Gao, Zhao-ling Qin, Hao Ren, Ping Zhao, Zhong-tian Qi. Inhibition of IRS-1 by hepatitis C virus infection leads to insulin resistance in a PTEN-dependent mannerVirology Journal 2015; 12(1): 12 doi: 10.1186/s12985-015-0241-4
11
C. Schnier, S. Wild, Z. Kurdi, C. Povey, D. J. Goldberg, S. J. Hutchinson. Matched population-based study examining the risk of type 2 diabetes in people with and without diagnosed hepatitis C virus infectionJournal of Viral Hepatitis 2016; 23(8): 596 doi: 10.1111/jvh.12520
12
Ayman Alsebaey, Mostafa Elhelbawy, Imam Waked. Platelets-to-lymphocyte ratio is a good predictor of liver fibrosis and insulin resistance in hepatitis C virus-related liver diseaseEuropean Journal of Gastroenterology & Hepatology 2018; 30(2): 207 doi: 10.1097/MEG.0000000000001013
13
Telma E. Silva, Marcelo F. Ronsoni, Leonardo L. Schiavon. Challenges in diagnosing and monitoring diabetes in patients with chronic liver diseasesDiabetes & Metabolic Syndrome: Clinical Research & Reviews 2018; 12(3): 431 doi: 10.1016/j.dsx.2017.12.013
14
Raoni Freitas Carvalho, Ajax Mercês Atta, Isabela Silva de Oliveira, Taciana Pereira Sant’Ana Santos, João Pedro A. Santos, Maria Isabel Schinoni, Maria Luiza Brito de Sousa-Atta. Adiponectin levels and insulin resistance among patients with chronic hepatitis CActa Tropica 2018; 178: 258 doi: 10.1016/j.actatropica.2017.12.004
15
Tram T. Tran, Darshan Mehta, Federico Mensa, Caroline Park, Yanjun Bao, Yuri Sanchez Gonzalez. Pan-Genotypic Hepatitis C Treatment with Glecaprevir and Pibrentasvir for 8 Weeks Resulted in Improved Cardiovascular and Metabolic Outcomes and Stable Renal Function: A Post-Hoc Analysis of Phase 3 Clinical TrialsInfectious Diseases and Therapy 2018; 7(4): 473 doi: 10.1007/s40121-018-0218-x
16
Roy Hall, Leigh Owens, Brenda Govan, Marie Caltabiano, Paula Clancy, Alanna Sorenson, Yvonne Cadet-James. The Impact of Prior Flavivirus Infections on the Development of Type 2 Diabetes Among the Indigenous AustraliansThe American Journal of Tropical Medicine and Hygiene 2016; 95(2): 265 doi: 10.4269/ajtmh.15-0727
17
Ratna B. Ray, Ranjit Ray. Hepatitis C Virus Manipulates Humans as its Favorite Host for a Long-Term RelationshipHepatology 2019; 69(2): 889 doi: 10.1002/hep.30214
18
N. K. T. Hlaing, R. A. Mitrani, S. T. Aung, W. W. Phyo, M. Serper, A. M. M. Kyaw, A. H. Bwa, K. M. Win, K. R. Reddy. Safety and efficacy of sofosbuvir-based direct-acting antiviral regimens for hepatitis C virus genotypes 1-4 and 6 in Myanmar: Real-world experienceJournal of Viral Hepatitis 2017; 24(11): 927 doi: 10.1111/jvh.12721
19
Geneviève F. Desrochers, Allison R. Sherratt, David R. Blais, Neda Nasheri, Zhibin Ning, Daniel Figeys, Natalie K. Goto, John Paul Pezacki. Profiling Kinase Activity during Hepatitis C Virus Replication Using a Wortmannin ProbeACS Infectious Diseases 2015; 1(9): 443 doi: 10.1021/acsinfecdis.5b00083
20
Nalan Okuroglu, Meltem Sertbas, Ali Ozdemir. Treatment of Chronic Hepatitis C Can Improve Glycemic Control in Patients with Type 2 DiabetesCase Reports in Hepatology 2018; 2018: 1 doi: 10.1155/2018/5260510
21
Ayman Alsebaey, Mostafa Elhelbawy. Insulin resistance is not a risk factor for oesophageal varices development in hepatitis CTropical Doctor 2019; 49(4): 281 doi: 10.1177/0049475519863231
22
Shimeng Xu, Xuelin Zhang, Pingsheng Liu. Lipid droplet proteins and metabolic diseasesBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2018; 1864(5): 1968 doi: 10.1016/j.bbadis.2017.07.019
23
Luciana D. Silva, Tatiana Bering, Gifone A. Rocha. The impact of nutrition on quality of life of patients with hepatitis CCurrent Opinion in Clinical Nutrition and Metabolic Care 2017; 20(5): 420 doi: 10.1097/MCO.0000000000000396
24
Yuki Haga, Tatsuo Kanda, Reina Sasaki, Masato Nakamura, Shingo Nakamoto, Osamu Yokosuka. Nonalcoholic fatty liver disease and hepatic cirrhosis: Comparison with viral hepatitis-associated steatosisWorld Journal of Gastroenterology 2015; 21(46): 12989-12995 doi: 10.3748/wjg.v21.i46.12989
25
Stephanie Klein, Jean-François Dufour. Nonalcoholic fatty liver disease and hepatocellular carcinomaHepatic Oncology 2017; 4(3): 83 doi: 10.2217/hep-2017-0013
26
Alaaeldin Abdelsalam Dawood, Mohamed Zakarya Nooh, Ayman Abdelhaleem Elgamal. Factors Associated with Improved Glycemic Control by Direct-Acting Antiviral Agent Treatment in Egyptian Type 2 Diabetes Mellitus Patients with Chronic Hepatitis C Genotype 4Diabetes & Metabolism Journal 2017; 41(4): 316 doi: 10.4093/dmj.2017.41.4.316
27
Ammon Handisurya, Corinna Kerscher, Andrea Tura, Harald Herkner, Berit Anna Payer, Mattias Mandorfer, Johannes Werzowa, Wolfgang Winnicki, Thomas Reiberger, Alexandra Kautzky-Willer, Giovanni Pacini, Marcus Säemann, Alice Schmidt, Jose Ignacio Herrero. Conversion from Tacrolimus to Cyclosporine A Improves Glucose Tolerance in HCV-Positive Renal Transplant RecipientsPLOS ONE 2016; 11(1): e0145319 doi: 10.1371/journal.pone.0145319
28
Chaoxing Li, Valentin Dinu. miR2Pathway: A novel analytical method to discover MicroRNA-mediated dysregulated pathways involved in hepatocellular carcinomaJournal of Biomedical Informatics 2018; 81: 31 doi: 10.1016/j.jbi.2018.03.013
29
Jing Liang, Chaoyang Lv, Minling Chen, Ming Xu, Chenhe Zhao, Yinqiu Yang, Jina Wang, Dong Zhu, Jian Gao, Ruiming Rong, Tongyu Zhu, Mingxiang Yu. Effects of preoperative hepatitis B virus infection, hepatitis C virus infection, and coinfection on the development of new‐onset diabetes after kidney transplantationJournal of Diabetes 2019; 11(5): 370 doi: 10.1111/1753-0407.12853
30
Chien-Hao Huang, Lung-Sheng Wu, Wen-Juei Jeng, Yu-Fu Cheng, Yu-Shien Ko, I-Shyan Sheen, Chun-Yen Lin, Giuseppina Novo. In HCV-related liver cirrhosis, local pulse wave velocity increases and in decompensated patients correlates with poorer survivalPLOS ONE 2019; 14(3): e0212770 doi: 10.1371/journal.pone.0212770
31
Mei-Yueh Lee, Wei-Chun Chen, Wei-Hao Hsu, Szu-Chia Chen, Jin-Ching Lee. Liraglutide Inhibits Hepatitis C Virus Replication Through an AMP Activated Protein Kinase Dependent MechanismInternational Journal of Molecular Sciences 2019; 20(18): 4569 doi: 10.3390/ijms20184569
32
Mostafa Elhelbawy, Wael Abdel-Razek, Ayman Alsebaey, Mohamed Hashim, Hassan Elshenawy, Imam Waked. Insulin resistance does not impair response of chronic hepatitis C virus to direct-acting antivirals, and improves with the treatmentEuropean Journal of Gastroenterology & Hepatology 2019; 31(1): 16 doi: 10.1097/MEG.0000000000001215
33
Ines Bilić-Ćurčić, Hrvoje Roguljić, Marul Ivandić, Aleksandar Včev, Robert Smolić, Martina Smolić. Update on Hepatitis C2017;  doi: 10.5772/intechopen.70721
34
Mohamed Salama, Manal Nomir, Maryan Fahmi, Amal El-Gayar, Mamdouh El-Shishtawy. Potential Role of Microfibrillar-Associated Protein 4, Fibrotic Indices and Oxidative Stress in Hepatocellular CarcinomaScientia Pharmaceutica 2018; 86(4): 44 doi: 10.3390/scipharm86040044
35
Jonathan G. Stine, Javelle A. Wynter, Blake Niccum, Virginia Kelly, Stephen H. Caldwell, Neeral L. Shah. Effect of Treatment with Direct Acting Antiviral on Glycemic Control in Patients with Diabetes Mellitus and Chronic Hepatitis CAnnals of Hepatology 2017; 16(2): 215 doi: 10.5604/16652681.1231581
36
Benli Jia, Dongsheng Yu, Gang Yu, Yunsheng Cheng, Yang Wang, Xiaoqiang Yi, Xiaoping Li, Yong Wang. Naringenin improve hepatitis C virus infection induced insulin resistance by increase PTEN expression via p53-dependent mannerBiomedicine & Pharmacotherapy 2018; 103: 746 doi: 10.1016/j.biopha.2018.04.110
37
Raymond Anthony Pashun, Nicole T. Shen, Arun Jesudian. Markedly Improved Glycemic Control in Poorly Controlled Type 2 Diabetes following Direct Acting Antiviral Treatment of Genotype 1 Hepatitis CCase Reports in Hepatology 2016; 2016: 1 doi: 10.1155/2016/7807921
38
Mashani Mohamad, Sarah Jayne Mitchell, Lindsay Edward Wu, Melanie Yvonne White, Stuart James Cordwell, John Mach, Samantha Marie Solon-Biet, Dawn Boyer, Dawn Nines, Abhirup Das, Shi-Yun Catherine Li, Alessandra Warren, Sarah Nicole Hilmer, Robin Fraser, David Andrew Sinclair, Stephen James Simpson, Rafael de Cabo, David George Le Couteur, Victoria Carroll Cogger. Ultrastructure of the liver microcirculation influences hepatic and systemic insulin activity and provides a mechanism for age-related insulin resistanceAging Cell 2016; 15(4): 706 doi: 10.1111/acel.12481
39
Carlos Esteban Coronel-Castillo, Xingshun Qi, Jocelyn Contreras-Carmona, Oscar Lenin Ramírez-Pérez, Nahum Méndez-Sánchez. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in HIV infection: a metabolic approach of an infectious diseaseExpert Review of Gastroenterology & Hepatology 2019; 13(6): 531 doi: 10.1080/17474124.2019.1599284
40
Franziska Wolter, Andreas Glässner, Benjamin Krämer, Pavlos Kokordelis, Claudia Finnemann, Dominik J. Kaczmarek, Felix Goeser, Philipp Lutz, Hans Dieter Nischalke, Christian P. Strassburg, Ulrich Spengler, Jacob Nattermann. Hypoxia impairs anti-viral activity of natural killer (NK) cells but has little effect on anti-fibrotic NK cell functions in hepatitis C virus infectionJournal of Hepatology 2015; 63(6): 1334 doi: 10.1016/j.jhep.2015.08.008
41
Petra Surlin, Dorin Nicolae Gheorghe, Liliana Foia, Amelia Surdu, Vasilica Toma, Sorina Mihaela Solomon, Dan Nicolae Florescu, Ion Rogoveanu. Hepatitis C - From Infection to Cure2018;  doi: 10.5772/intechopen.76135
42
Kara W. Chew, Chia-Ying Liu, Bharath Ambale-Venkatesh, Diana Liao, Tamara B. Horwich, João A.C. Lima, David A. Bluemke, J. Paul Finn, Adeel A. Butt, Judith S. Currier. Subclinical myocardial disease by cardiac magnetic resonance imaging and spectroscopy in healthy HIV/Hepatitis C virus-coinfected personsJournal of International Medical Research 2017; 45(6): 1693 doi: 10.1177/0300060517708919